The top 10 pharma R&D budgets in 2018


Big Pharmas are still the biggest spenders in drug R&D, and the numbers are impressive: Last year, and for the first time, the top 15 largest companies (by sales) funneled more than $100B into research! The FDA also approved more drugs than ever before! See who made the top 10 list of pharma R&D budgets in 2018 below:

  1. Roche
  2. Johnson & Johnson
  3. Merck & Co.
  4. Novartis
  5. Pfizer
  6. Sanofi
  7. Bristol-Myers Squibb
  8. AstraZeneca
  9. Eli Lilly
  10. GlaxoSmithKline

Read the full report at…


Comments are closed.

More in Ashton Tweed Connection
The top 20 highest-paid biopharma CEOs of 2018

As in past years, FiercePharma has tracked yearly data to compile the top CEO pay packages in biopharma, ranging from...